166 related articles for article (PubMed ID: 32950451)
21. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
[TBL] [Abstract][Full Text] [Related]
22. Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
Culotta V; Moon JC
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):888-889. PubMed ID: 27514622
[No Abstract] [Full Text] [Related]
23. Yet another amyloidosis.
Means RT
J Investig Med; 2022 Feb; 70(2):347. PubMed ID: 34965957
[No Abstract] [Full Text] [Related]
24. Transthyretin Amyloidosis: A "Zebra" of Many Stripes.
Semigran MJ
J Am Coll Cardiol; 2016 Jul; 68(2):173-5. PubMed ID: 27386770
[No Abstract] [Full Text] [Related]
25. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
26. Emerging Advances in the Management of Cardiac Amyloidosis.
Vranian MN; Sperry BW; Valent J; Hanna M
Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453
[TBL] [Abstract][Full Text] [Related]
27. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
[TBL] [Abstract][Full Text] [Related]
28. Imaging Techniques as an Aid in the Early Detection of Cardiac Amyloidosis.
Santarelli MF; Scipioni M; Genovesi D; Giorgetti A; Marzullo P; Landini L
Curr Pharm Des; 2021; 27(16):1878-1889. PubMed ID: 32787756
[TBL] [Abstract][Full Text] [Related]
29. Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis.
Rapezzi C; Tinuper AL; Lorenzini M
J Am Coll Cardiol; 2017 Jul; 70(4):478-480. PubMed ID: 28728693
[No Abstract] [Full Text] [Related]
30. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Magnetic Resonance T
Duca F; Kammerlander AA; Panzenböck A; Binder C; Aschauer S; Loewe C; Agis H; Kain R; Hengstenberg C; Bonderman D; Mascherbauer J
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1924-1926. PubMed ID: 30121265
[No Abstract] [Full Text] [Related]
32.
Schindler TH; Sharma V; Imperiale A
JACC Cardiovasc Imaging; 2021 Jan; 14(1):256-258. PubMed ID: 32771579
[No Abstract] [Full Text] [Related]
33. Early Phase
Galat A; Van der Gucht A; Guellich A; Bodez D; Cottereau AS; Guendouz S; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T; Rosso J
JACC Cardiovasc Imaging; 2017 May; 10(5):601-603. PubMed ID: 27424245
[No Abstract] [Full Text] [Related]
34. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
36. Light-chain cardiac amyloidosis.
Mankad AK; Sesay I; Shah KB
Curr Probl Cancer; 2017; 41(2):144-156. PubMed ID: 28117074
[TBL] [Abstract][Full Text] [Related]
37. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
[TBL] [Abstract][Full Text] [Related]
38. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
39. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
[TBL] [Abstract][Full Text] [Related]
40. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
